Investors Research Corp Amarin Corp Plcuk Transaction History
Investors Research Corp
- $493 Million
- Q2 2025
A detailed history of Investors Research Corp transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Investors Research Corp holds 61 shares of AMRN stock, worth $929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 1,225
95.02%
Holding current value
$929
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AMRN
# of Institutions
136Shares Held
68.2MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$379 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$189 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$57.8 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$51.8 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$40 Million0.0% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.14B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...